Critical Care Medicine: Principles of Critical Care — Comprehensive Support

Added 3 August 2026

Comprehensive Support of the Critically Ill Patient

Modern intensive care is delivered by an interdisciplinary team — nurses, physicians, pharmacists, respiratory therapists, physical and occupational therapists, advanced practice providers, case managers, and social workers — and the best team dynamics rest on explicit recognition of each member’s role, shared communication models, and an environment of psychological safety. The usual goals of care are to restore health and return the patient home while minimizing hospital time, medical complications, and the long-term effects of critical illness. When disease is overwhelming or irreversible, goals shift toward comfort and dignity at the end of life.

Because critically ill patients are at risk for a predictable set of hospital-acquired conditions — health care–associated infections, skin and soft tissue pressure injury, malnutrition, gastrointestinal bleeding, delirium, and weakness — protocolized care is the backbone of ICU safety. Protocols should be evidence-based and reviewed periodically for accuracy. The complexity of critical illness also favors a methodical, organ system–based approach to daily rounds, reviewing the main disease process, the affected organs and systems, and the related interventions.

Goals of care should drive every ICU decision. The default goal is to restore health and return the patient home while minimizing complications and the long-term effects of critical illness — but in overwhelming or irreversible disease, goals should shift to comfort and dignity at the end of life. Withholding and withdrawing life-sustaining treatment are ethically equivalent, and when either is chosen, aggressive attention to analgesia and anxiolysis is required. Meet regularly with the patient or surrogate to discuss prognosis, and ensure the care provided aligns with the patient’s own preferences.
Stress ulcer prophylaxis is not for every ICU patient. Acid suppression reduces clinically significant bleeding in at-risk patients but has not improved mortality — and trials found no difference in pneumonia or Clostridioides difficile infection — so guidelines give only a weak recommendation, limited to high-risk patients (coagulopathy, chronic liver disease, or mechanical ventilation). Proton pump inhibitors appear more effective than H2 blockers at preventing bleeding, although concerns about infectious risk persist.

Sedation and Analgesia: Treat Pain First

Most ICU patients require both analgesia and sedation, and the contemporary approach is analgesia first. Pain should be assessed with an objective scale at least every 4 hours, and preemptive analgesia should be provided before painful procedures such as arterial line or thoracostomy tube insertion. Opiates remain the mainstay of therapy, but multimodal strategies — combining nonpharmacologic techniques and non-opiate drugs — improve pain control and reduce total opiate exposure (Table 1). Nonpharmacologic options include music therapy, massage, relaxation techniques, local cold therapy for procedures, and family involvement; pharmacologic adjuncts include acetaminophen, low-dose ketamine in postsurgical patients, and gabapentin, carbamazepine, or pregabalin for neuropathic pain, with an opiate or NSAID given preprocedurally.

Table 1. Summary of Analgesia and Sedation Recommendations
Analgesia — nonpharmacologicMusic therapy; massage therapy; relaxation therapy; local cold therapy for procedures; family involvement; daily sedation interruption
Analgesia — pharmacologicOpiates remain the mainstay; multimodal therapy (nonpharmacologic and non-opiate); consider opiate-reduction strategies; adjunct acetaminophen; adjunct low-dose ketamine for postsurgical patients; adjunct gabapentin, carbamazepine, or pregabalin for neuropathic pain; preprocedural analgesia with an opiate or NSAID
SedationLight rather than deep sedation in mechanically ventilated patients; sedation protocols (nurse-driven); daily sedation interruption; favor propofol or dexmedetomidine over benzodiazepines; titrate to an objective scale; bispectral index monitoring when scales cannot be used (e.g., neuromuscular blockers)

Once pain is controlled, sedation addresses the remaining needs — anxiolysis, relief of subjective dyspnea, suppression of autonomic hyperactivity that could precipitate myocardial ischemia, and reduction of total oxygen consumption. Like analgesia, sedation must be monitored and titrated with an objective scale such as the Richmond Agitation-Sedation Scale (RASS). Guidelines favor light sedation, often achievable with intermittent opiate dosing alone; when continuous sedation is required, propofol or dexmedetomidine is preferred over benzodiazepines, which are associated with increased delirium. Nurse-driven sedation protocols and daily interruption of sedation are standard elements of care, and a bispectral index monitor can assess depth of sedation when clinical scales cannot be used, such as during neuromuscular blockade.

Sedate lightly — and measure it. Keep mechanically ventilated patients at light sedation, titrated to an objective scale such as RASS, using sedation protocols (ideally nurse-driven) with daily interruption of sedation. When continuous sedation is needed, favor propofol or dexmedetomidine over benzodiazepines.
No sedative has proven superior — light-sedation targets and protocols matter more than agent choice. In the AID-ICU trial (~3,400 ventilated adults), dexmedetomidine did not reduce 90-day mortality compared with usual-care sedation (mostly propofol; ~34% vs ~33%) and caused more bradycardia and hypotension, with only modestly more coma- and delirium-free days. The pragmatic A2B trial (1,404 patients) found no difference between alpha-2 agonists (dexmedetomidine or clonidine) and propofol in time to extubation, 90-/180-day mortality, or delirium — and ~50% more agitation plus more severe bradycardia with alpha-2 agonists. Choose the sedative to fit the patient rather than following a drug-first hierarchy. [3] [4]

Daily protocolized interruption of sedation and analgesia shortens the duration of mechanical ventilation and ICU stay and reduces the incidence of delirium, although a 90-day mortality benefit has not been shown; protocolized light sedation achieves similar patient outcomes. Because sedatives and opiates accumulate in hepatic or renal dysfunction, prolonged infusions deserve particular vigilance. Neuromuscular blocking agents (e.g., cisatracurium) are reserved for severe ventilator dyssynchrony despite optimal sedation — typically in severe ARDS — and because they paralyze without altering consciousness, sedative-induced amnesia is mandatory whenever they are used; prolonged courses risk a postparalytic myopathy.

Oversedation has a protocol, not a dilemma. When a patient is deeper than target, stop the sedative until the level of sedation is appropriate, then restart it at half the previous dose. Remember that drug accumulation in hepatic or renal dysfunction can mimic neurologic deterioration — and that a paralyzed patient cannot signal awareness, so amnesia is mandatory whenever neuromuscular blockers are used.

Delirium

Delirium is an acute change in cognitive function developing over hours to days and fluctuating during the day: inattention, disorganized thinking, executive dysfunction, altered level of consciousness (from lethargy to hypervigilance), perceptual disturbances (hallucinations or delusions), altered psychomotor activity, sleep-wake disruption, and labile mood. It is extremely common in the ICU and is associated with longer stays, greater morbidity and mortality, and post–intensive care cognitive impairment. Risk factors include benzodiazepine exposure, blood transfusion, pre-existing dementia, older age, previous coma, surgery or trauma before ICU admission, and high severity of illness. Patients should be monitored with a validated tool such as the Confusion Assessment Method–ICU (CAM-ICU) or the Intensive Care Delirium Screening Checklist.

The differential diagnosis of ICU delirium is broad — sepsis, sedatives and analgesics, drug withdrawal, metabolic and electrolyte derangements, intracranial pathology, seizures, hypoxia, shock, and vitamin deficiencies — so treatment begins with identifying and correcting the underlying cause. Large randomized studies have failed to demonstrate any medication effective for preventing or treating delirium; antipsychotics remain controversial, and benzodiazepines should not be used unless treating alcohol withdrawal or seizures. Prevention is multicomponent and nonpharmacologic: early mobilization, preservation of nocturnal sleep, adequate pain management, reorientation of the patient, removal of vascular and urethral catheters, provision of visual and hearing aids, minimization of nonessential medications, adequate nutrition and hydration, and family engagement — the elements organized in the ABCDEF bundle (Table 2).

Table 2. ABCDEF Care Bundle for Managing Delirium in the ICU
AAssess, prevent, and manage pain
BPerform both SAT and SBT (spontaneous awakening trial and spontaneous breathing trial)
CChoice of analgesia and sedation
DDelirium: assessment, prevention, and management
EEarly mobility and exercise
FFamily engagement and empowerment
Do not reach for benzodiazepines (or antipsychotics) to treat ICU delirium. No medication has proven efficacy for preventing or treating delirium, antipsychotics offer no conclusive benefit, and benzodiazepines are themselves a delirium risk factor. Reserve benzodiazepines for alcohol withdrawal or seizures.
Delirium: still no winning drug — and the ABCDEF bundle’s RCT evidence is thinner than its widespread adoption suggested. A 2024 synthesis of placebo-controlled trials (including MIND-USA, AID-ICU, and EuRIDICE) confirms that haloperidol, quetiapine, and other agents do not reduce delirium duration, coma, or mortality; dexmedetomidine may help manage delirious agitation but does not prevent delirium. Prevention remains nonpharmacologic — sleep promotion, reorientation, mobility, family engagement. Meanwhile, the first randomized trial of the complete ABCDEF bundle found that full adherence did not reduce delirium incidence (~38% in both groups) or delirium duration versus usual care; the benefits seen in observational cohorts remain unproven by RCT evidence. [9] [10]

Nutritional Support

Malnutrition increases morbidity and mortality in critical illness, so every ICU patient should receive a nutritional evaluation. Enteral nutrition should start within 24 to 48 hours of admission — early enteral feeding is associated with lower mortality and fewer infections — and the enteral route is preferred unless a contraindication is present (e.g., bowel perforation or active hemorrhage). Patients receiving vasopressors, neuromuscular blockers, hypothermia, or extracorporeal life support should be fed enterally as soon as they can tolerate it. Critically ill patients unable to maintain volitional intake should be fed as soon as possible via a gastric tube, large-bore tube, small-bore tube, or postpyloric tube; postpyloric feeding is recommended when a high risk for aspiration exists, but delays in placing a postpyloric tube should not delay the initiation of enteral nutrition.

Two practices deserve caution once enteral feeding is under way: routine measurement of gastric residuals is no longer recommended, and the timing of supplemental parenteral nutrition matters — it should be considered only after 7 to 10 days of meeting less than 60% of energy and protein requirements by the enteral route alone. Parenteral nutrition carries its own complications (hyperglycemia, fatty liver, cholestasis, and sepsis), and delaying supplemental parenteral nutrition until about day 8 of the ICU stay improves recovery and reduces ICU-related complications. Conversely, parenteral nutrition should be started as soon as possible for severely malnourished patients, those at high risk for malnutrition, and those in whom enteral nutrition is not possible. Glycemic control accompanies nutritional support: guidelines favor targeting glucose of 180 mg/dL or less rather than aggressive normalization, which increases hypoglycemia and mortality.

Feed the gut early. Start enteral nutrition within 24–48 hours of ICU admission unless a contraindication is present (perforation, hemorrhage); early enteral feeding is associated with lower mortality and fewer infections. Patients on vasopressors, neuromuscular blockers, hypothermia, or extracorporeal support should be fed enterally as soon as they can tolerate it.
Two once-routine feeding practices have fallen out of favor. Routine gastric residual measurement is not recommended — it delays achievement of feeding goals, increases the risk of clogging the enteral access, and may increase the risk of aspiration. And supplemental parenteral nutrition should wait until after 7–10 days of meeting <60% of energy and protein needs enterally; adding it earlier may cause harm and should be avoided. Start parenteral nutrition early only in severely malnourished or high-risk patients, or when enteral feeding is impossible.
ESPEN 2023 practical guideline for ICU nutrition. The revised guideline recommends early enteral nutrition within 48 hours when feasible; hypocaloric feeding (<70% of estimated energy expenditure) for up to 7 days during the acute phase; indirect calorimetry as the preferred method for setting energy targets; protein intake of at least 1.3 g/kg/day; and parenteral nutrition within 3–7 days if enteral nutrition is contraindicated. [5]
In shock, go slow early — and more protein is not better. NUTRIREA-3 showed that low-calorie/low-protein feeding for the first 7 days reduced mortality in ventilated adults with shock compared with standard-calorie/protein feeding, supporting caution against aggressive early full feeding and overfeeding. Meanwhile, the EFFORT Protein trial found that high-dose protein (≥2.2 g/kg/day) in nutritionally high-risk patients did not improve 90-day mortality or functional outcomes versus usual protein intake, tempering earlier aggressive high-protein strategies. [6] [7]

Early Mobilization

Weakness in critical illness is multifactorial — immobility, the disease itself, medications, and medical interventions all contribute. Immobility alone can cause muscular weakness, joint stiffness, pressure ulcers, osteoporosis, gastrointestinal dysmotility, and dysautonomia, and even a few days of bed rest can have prolonged effects: long-term follow-up of critical illness survivors demonstrates persistent weakness at 1 and 5 years. Mobilization strategies that combine interruption of sedation with physical and occupational therapy in the earliest days of critical illness are associated with shorter ICU and hospital stays, fewer days of mechanical ventilation, and improvements in functional status and quality of life; very early physical and occupational therapy in ventilated patients also reduces delirium and improves functional independence at hospital discharge. ICU-acquired weakness — neuropathies and myopathies that typically emerge after about a week in the ICU — is the syndrome these efforts aim to prevent.

Mobilize early — and safely. Pairing sedation interruption with physical and occupational therapy in the earliest days of critical illness shortens ICU and hospital stay and days of mechanical ventilation, improves functional status and quality of life, and helps prevent ICU-acquired weakness, which can persist for years.
The TEAM trial tempered “mobilize aggressively and early.” In ~7,000 ventilated patients, early active mobilization within 72 hours did not improve survival or functional outcomes versus usual care and was associated with more adverse events. The takeaway is not to abandon mobilization but to individualize it: gradual mobilization as tolerated remains reasonable, while pushing aggressive early mobilization in unstable patients is no longer supported. [8]

ICU Care Bundles

A care bundle is a small series of interventions that have been shown to improve patient outcomes when used together, and bundles help clinicians monitor patients and guide appropriate interventions. Three bundles widely applied in critical care address ventilator-associated pneumonia, central line–associated bloodstream infection, and sepsis (Table 3). The infection-prevention elements are reinforced by ICU infection-control data: strict adherence to hand hygiene, full-barrier precautions at insertion, chlorhexidine skin preparation, avoidance of the femoral site, and timely catheter removal measurably reduces device-related infections — and the longer any invasive device remains in place, the greater the infection risk.

Table 3. ICU Care Bundles
Ventilator-associated pneumoniaHead of bed elevated at least 30 degrees; daily sedation interruption and assessment of readiness to extubate; endotracheal tubes with subglottic suction; early exercise or mobilization for physical conditioning; change ventilator circuits only if malfunctioning or visibly soiled
Central line–associated bloodstream infectionHand hygiene; maximal barrier precautions; chlorhexidine skin antisepsis; avoid femoral access; daily review of line necessity
Sepsis (1-hour bundle)Measure lactate level; obtain blood cultures before antibiotics; administer broad-spectrum antibiotics; give 30 mL/kg crystalloid for hypotension or lactate ≥4 mmol/L; use vasopressors if no response to fluids — keep MAP ≥65 mm Hg
Bundles work because every element is done, every time. The sepsis 1-hour bundle — measure lactate, obtain blood cultures before antibiotics, give broad-spectrum antibiotics, administer 30 mL/kg crystalloid for hypotension or lactate ≥4 mmol/L, and start vasopressors if fluids fail (target MAP ≥65 mm Hg) — is the time-critical example; the VAP and CLABSI bundles prevent harm through the same all-or-nothing discipline.

High-Value Care in the ICU

Critical care accounts for a large share of U.S. health care spending, yet survival and quality-of-life outcomes are not clearly better than in other high-income countries — an argument for high-value care, defined as care that balances clinical benefit against cost and harm to improve patient outcomes. The ICU is a high-leverage setting: resources are expensive, and the culture favors aggressive resource use. Through the American Board of Internal Medicine Foundation’s Choosing Wisely campaign, internal medicine and critical care societies promote cost-effective strategies that improve patient care and avoid waste and harm. The 2021 Society of Critical Care Medicine recommendations target five overused practices: (1) retaining catheters and drains without a clear indication; (2) delaying discontinuation of mechanical ventilation; (3) continuing antibiotic therapy without need; (4) delaying mobilization of critically ill patients; and (5) providing care without ensuring that it aligns with patient preferences. The earlier 2014 list also recommended against daily routine laboratory testing.

High value = benefit balanced against cost and harm. The ICU’s Choosing Wisely list doubles as a daily-rounds checklist: remove catheters and drains that lack a clear indication, liberate from the ventilator promptly, stop antibiotics that are no longer needed, mobilize early, skip routine daily labs — and above all, ensure the care provided aligns with the patient’s own preferences.

References

  1. MKSAP 19 — Pulmonary and Critical Care MedicineAmerican College of Physicians (2022). "Critical Care Medicine: Principles of Critical Care," pp. 59-62.
  2. Harrison's Principles of Internal Medicine, 22eMcGraw-Hill (2024). "Approach to the Patient with Critical Illness" (Ch.311, Baron/Massaro), pp. 2291-2298.
  3. AID-ICU trial — dexmedetomidine vs usual-care sedation: no mortality benefitAndersen LH, et al. N Engl J Med 2024;391(5):427-437.
  4. A2B trial — alpha-2 agonist vs propofol sedation: no difference in time to extubation or mortalityWalsh TS, Parker RA, Aitken LM, et al. JAMA 2025;334(1):32-45.
  5. ESPEN practical guideline: clinical nutrition in the ICU (2023 revision)Singer P, Blaser AR, Berger MM, et al. Clin Nutr 2023;42(9):1671-1689.
  6. NUTRIREA-3 — hypocaloric feeding in shock reduced mortality vs standard feedingReignier J, Plantefeve G, Mira JP, et al. Lancet Respir Med 2023;11(7):602-612.
  7. EFFORT Protein — high-dose protein in nutritionally high-risk ICU patients: no outcome benefitHeyland DK, Patel J, Compher C, et al. Lancet 2023;401(10376):568-576.
  8. TEAM trial — early active mobilization in the ICU: no outcome benefit, more adverse eventsHodgson CL, Bellomo R, Berney SM, et al. N Engl J Med 2022;387(21):1901-1911.
  9. First randomized trial of the ABCDEF bundle — complete adherence did not reduce ICU deliriumCrit Care Med 2026 (e-pub Jan 2026; PMID 42159452).
  10. ICU delirium pharmacotherapy — no drug prevents or treats delirium (2024 synthesis)Northam KA, Phillips KM. NEJM Evid 2024;3(11).
Critical Care Medicine: Principles of Critical Care — Comprehensive Support
0%
Added 3 August 2026